Test–retest reliability of fMRI verbal episodic memory paradigms in healthy older adults and in persons with mild cognitive impairment
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
This study investigated test–retest functional magnetic resonance imaging (fMRI) reproducibility in 10 healthy older adults and in 10 mild cognitive impairment (MCI) persons using a two‐condition (encoding and retrieval) verbal episodic memory task as well as a two‐condition (with and without a motor response) phonological processing task. Reproducibility measures included an overlap ratio with four different thresholds, statistical comparisons of the condition contrasts across sessions (test–retest contrasts), ANCOVAs, and intraclass correlation (ICC) on selected regions of interests (ROIs). In all four conditions and for all reproducibility measures, MCI individuals showed fMRI test–retest reproducibility indices that were comparable to those of healthy older adults. At the group level, the comparison of the test–retest condition contrasts yielded very few differences in the areas and level of activation and those differences tended to show a slight reduction of activation in the second session. In addition, the results from the ANCOVAs showed that the fMRI signal measured at the group level does not vary significantly from one session to another. Overlap ratios, however, showed that the fMRI signal failed to produce a reliable pattern of significantly activated voxels across sessions. ICC analyses on selected ROIs indicated that there is high within‐subject variability, suggesting reduced reliability at the individual level. Overall, these findings indicate that MCI individuals show fMRI test–retest reproducibility comparable to those of healthy controls and hence that MCI do not alter fMRI reproducibility. Furthermore, they indicate that monitoring treatment effects is reliable when comparing groups but reduced when comparing single individuals. These results have precise implications for the design of longitudinal studies relying on fMRI measures in older adults. Hum Brain Mapp, 2009. © 2009 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
. Cerebral blood flow in dementia.
Hachinski, V. C., Iliff, L. D., Zilhka, E., Du Boulay, G. H., McAllister, V. L., Marshall, J., Russell, R. W. R., & Symon, L. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510088009 · Cited by 3,186
Effects of Cognitive Training Interventions With Older Adults: A Randomized Controlled Trial
Ball, K., Berch, D. B., Helmers, K. F., Jobe, J. B., Leveck, M. D., Marsiske, M., Morris, J. N., Rebok, G. W., Smith, D. M., Tennstedt, S. L., et al. (2002) · JAMA · doi:10.1001/jama.288.18.2271 · Cited by 2,049 · cited 1×
“…studies have investigated the possibility of pharmaceutical [e.g. Gron et al., 2006; Saykin et al., 2004] and nonpharmaceutical interventions [e.g. Ball et al., 2002; Belleville et al., 2006; Craik et al., 2007; Rapp et al., 2002] to enhance mnesic abilities in healthy older adults and in persons…”
BackgroundMild Cognitive Impairment as a Clinical Entity and Treatment Target
Petersen, R. C., & Morris, J. C. (2005) · Archives of Neurology · doi:10.1001/archneur.62.7.1160 · Cited by 935 · cited 2×
“…2004] and nonpharmaceutical interventions [e.g. Ball et al., 2002; Belleville et al., 2006; Craik et al., 2007; Rapp et al., 2002] to enhance mnesic abilities in healthy older adults and in persons with MCI or to at least slow the initial rate of progression toward AD [Petersen and Morris, 2005].”
BackgroundHuman Functional Neuroimaging of Brain Changes Associated with Practice
Kelly, A. M. C., & Garavan, H. (2005) · Cerebral Cortex · doi:10.1093/cercor/bhi005 · Cited by 752
Cited by
Brain Imaging in Alzheimer Disease
Johnson, K. A., Fox, N. C., Sperling, R. A., & Klunk, W. E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006213 · Cited by 875
“BOLD fMRI response is known to be variable across subjects, and very few studies examining the reproducibility of fMRI activation in older and cognitively impaired subjects have been published to date (Clement and Belleville 2009; Putcha et al. 2010).”
BackgroundFunctional Alterations in Memory Networks in Early Alzheimer’s Disease
Sperling, R. A., Dickerson, B. C., Pihlajamaki, M., Vannini, P., LaViolette, P. S., Vitolo, O. V., Hedden, T., Becker, J. A., Rentz, D. M., Selkoe, D. J., et al. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8109-7 · Cited by 604
How reliable are the results from functional magnetic resonance imaging?
Bennett, C. M., & Miller, M. B. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05446.x · Cited by 577
Training-related brain plasticity in subjects at risk of developing Alzheimer’s disease
Belleville, S., Clément, F., Mellah, S., Gilbert, B., Fontaine, F., & Gauthier, S. (2011) · Brain · doi:10.1093/brain/awr037 · Cited by 386
Self-citationEndophenotype: a conceptual analysis
Kendler, K. S., & Neale, M. C. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.8 · Cited by 373
Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline
O'Brien, J. L., O'Keefe, K. M., LaViolette, P. S., DeLuca, A. N., Blacker, D., Dickerson, B. C., & Sperling, R. A. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e3966e · Cited by 299
Brain imaging of neurovascular dysfunction in Alzheimer’s disease
Montagne, A., Nation, D. A., Pa, J., Sweeney, M. D., Toga, A. W., & Zlokovic, B. V. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1570-0 · Cited by 239
“Some studies have shown moderate-to-excellent test–retest reproducibility of fMRI activation in older and cognitively impaired participants [11, 40, 73, 134, 196].”
The potential of functional MRI as a biomarker in early Alzheimer's disease
Sperling, R. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.009 · Cited by 187
“, 2010) and very few reproducibility tudies in older and cognitively impaired subjects have been ublished to date (Clement and Belleville, 2009; Putcha et l., 2011).”
BackgroundBritton, J. C., Bar-Haim, Y., Clementi, M. A., Sankin, L. S., Chen, G., Shechner, T., Norcross, M. A., Spiro, C. N., Lindstrom, K. M., & Pine, D. S. (2013) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2012.11.001 · Cited by 101
“Few studies have examined the test–retest reliability of neural activation in cognitive/affective tasks (Clement and Belleville, 2009; Plichta et al., 2012); however, in prior work, the sample sizes vary between 10 and 25 individuals, yet this range encompasses the current sample size (n = 12).”
Lutein and Zeaxanthin Influence Brain Function in Older Adults: A Randomized Controlled Trial
Lindbergh, C. A., Renzi-Hammond, L. M., Hammond, B. R., Terry, D. P., Mewborn, C. M., Puente, A. N., & Miller, L. S. (2018) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617717000534 · Cited by 94
“Consistent with prior studies (e.g., Bookheimer et al., 2000, 2013; Cabeza & Nyberg, 2000; Clément & Belleville, 2009), ROIs during learning trials included medial temporal lobe, supramarginal and angular gyri, precuneus, dorsolateral and ventrolateral prefrontal cortex, anterior and posterior…”
MethodResultExplainable Artificial Intelligence in Neuroimaging of Alzheimer’s Disease
Taiyeb Khosroshahi, M., Morsali, S., Gharakhanlou, S., Motamedi, A., Hassanbaghlou, S., Vahedi, H., Pedrammehr, S., Kabir, H. M. D., & Jafarizadeh, A. (2025) · Diagnostics · doi:10.3390/diagnostics15050612 · Cited by 68
Metadata
- Authors
- Clément, F., & Belleville, S.
- Venue
- Human Brain Mapping
- Publisher
- Wiley
- Published
- 2009-11-17
- Volume
- 30
- Issue
- 12
- Pages
- 4033-4047
- ISSN
- 1065-9471 (ISSN-L)
- 1097-0193
- OpenAlex
- W2094494248
- Cited by
- 64
- References
- 5
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.